Effects of different carriers for adsorption of 125I on brachytherapy sources

被引：0
作者：
Ghahramani, M. R. [1 ]
Asgharizadeh, F. [1 ]
Assadi, M. R. [1 ]
Ahmadi, S. J. [1 ]
Moradi, K. [1 ]
机构：
[1] Atom Energy Org Iran, Nucl Res & Technol Res Sch, Tehran, Iran
来源：
IRANIAN JOURNAL OF RADIATION RESEARCH | 2012年 / 10卷 / 02期
关键词：
I-125; brachytherapy; seed source; MALIGNANT BRAIN-TUMORS; INTERSTITIAL BRACHYTHERAPY; PD-103; CANCER; SEED; EYE;
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
Background: One of the key techniques for the preparation of I-125 seeds is adsorption of I-125 onto silver bits coated by palladium (pd). Carriers played an important role in the adsorption of I-125 on palladium. KI is used as a carrier for fixing of I-125 onto silver wire bits coated with palladium. Materials and Methods: Three procedures KI, KOH, NH4OH were investigated for adsorption of I-125 activity by different carriers. Results: Adsorptions percentage of I-125 on treated silver beads showed about 85% by using KI as a carrier, the KOH showed 74% and 65% for NH4OH. Conclusion: The results indicated that, the use of KI as a carrier was suitable for adsorption of I-125 on treated silver seeds with Pd than KOH and NH4OH. Iran. J. Radiat. Res., 2012; 10(2): 105-107
引用
收藏
页码：105 / 107
页数：3
相关论文
共 50 条
  • [41] An in vitro verification of strength estimation for moving an 125I source during implantation in brachytherapy
    Tanaka, Kenichi
    Kajimoto, Tsuyoshi
    Hayashi, Takahiro
    Asanuma, Osamu
    Hori, Masakazu
    Kamo, Ken-ichi
    Sumida, Iori
    Takahashi, Yutaka
    Tateoka, Kunihiko
    Bengua, Gerard
    Sakata, Koh-ichi
    Endo, Satoru
    JOURNAL OF RADIATION RESEARCH, 2018, 59 (04) : 484 - 489
  • [42] Near-field dosimetry of 125I sources for interstitial brachytherapy implants measured using thermoluminescent sheets
    Iwata, K
    Yue, NJ
    Nath, R
    MEDICAL PHYSICS, 2004, 31 (12) : 3406 - 3416
  • [43] Comparison of 3 different postimplant dosimetry methods following permanent 125I prostate seed brachytherapy
    Marcu, Loredana G.
    Gowda, Raghu
    MEDICAL DOSIMETRY, 2013, 38 (03) : 309 - 314
  • [44] Indigenous 125I Brachytherapy Source for the Management of Intraocular Melanomas in India
    Shah, Parag K.
    Selvaraj, Ulagiappa
    Narendran, Venkatapathy
    Guhan, Pandurangan
    Saxena, Sanjay Kumar
    Dash, Ashutosh
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2013, 28 (01) : 21 - 28
  • [45] Custom-made "Nag" eye plaques for 125I brachytherapy
    Nag, S
    Wang, D
    Wu, H
    Bauer, CJ
    Chambers, RB
    Davidorf, FH
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 56 (05): : 1373 - 1380
  • [46] Quadrant dosimetry as a predictor of biochemical relapse in 125I prostate brachytherapy
    Spadinger, Ingrid
    Morris, W. James
    Keyes, Mira
    Liu, Mitchell
    Shaffer, Richard
    Thompson, Anna
    Chng, Nicholas
    Woods, Ryan
    BRACHYTHERAPY, 2011, 10 (02) : 87 - 97
  • [47] Experimental determination of dosimetric characteristics of Best® 125I brachytherapy source
    Meigooni, AS
    Gearheart, DM
    Sowards, K
    MEDICAL PHYSICS, 2000, 27 (09) : 2168 - 2173
  • [48] 125I brachytherapy for localized prostate cancer: a single institution experience
    Guarneri, Alessia
    Botticella, Angela
    Filippi, Andrea Riccardo
    Munoz, Fernando
    Beltramo, Giancarlo
    Casetta, Giovanni
    Giglioli, Francesca Romana
    Tizzani, Alessandro
    Ragona, Riccardo
    Ricardi, Umberto
    TUMORI JOURNAL, 2013, 99 (01): : 83 - 87
  • [49] Monte Carlo dosimetry of the selectSeed 125I interstitial brachytherapy seed
    Karaiskos, P
    Papagiannis, P
    Sakelliou, L
    Anagnostopoulos, G
    Baltas, D
    MEDICAL PHYSICS, 2001, 28 (08) : 1753 - 1760
  • [50] Model-based dose calculations for 125I lung brachytherapy
    Sutherland, J. G. H.
    Furutani, K. M.
    Garces, Y. I.
    Thomson, R. M.
    MEDICAL PHYSICS, 2012, 39 (07) : 4365 - 4377
12345